NEWSROOM | Galderma

Galderma launches Alastin® in China, supporting the skin’s natural regenerative abilities in a rapidly expanding market

EADV 2025: scientific presentations supported by Galderma

Advancing the future of dermatology with robust IT

Galderma introduces Cetaphil Nourishing Oil to Foam Cleanser, a breakthrough in hydrating cleansing for sensitive skin

10 years of GAIN: inspiring aesthetic education and excellence

Galderma delivers record first half 2025 net sales of 2.448 billion USD and 12.2% year-on-year growth at constant currency, raises full-year top-line guidance

More than skin deep: the daily reality of atopic dermatitis

Galderma unveils final nine-month data showing lasting efficacy and patient satisfaction with its Injectable Aesthetics portfolio when addressing facial aesthetic changes after medication-driven weight loss

Scratching the Surface: shedding light on a misunderstood skin disease

Galderma announces departure of its Chief Financial Officer

Breaking through the surface of sensitive skin

Galderma initiates two new clinical trials investigating nemolizumab in patients with Systemic Sclerosis and Chronic Pruritus of Unknown Origin